AD is characterized by increased cerebral amyloid-beta (Aβ) accumulation that precedes cognitive impairment and phosphorylated tau (P-tau) that increases in direct correlation with cognitive change (2). The gene discussed is MAPT; the disease is Alzheimer disease.